Century Therapeutics to Participate in Upcoming Investor Conferences in March

About this update from Century Therapeutics, Inc.

PHILADELPHIA , Feb. 25, 2026 (GLOBE NEWSWIRE) -- Century Therapeutics, Inc. (‘Century’, NASDAQ: IPSC), a biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies for autoimmune diseases, including type 1 diabetes, and cancer, today announced that the company will participate in the following upcoming investor conferences in March: TD Cowen 46th Annual Health Care Conference : Fireside chat at 9:50 a.m. ET on Wednesday, March 4, 2026 , in Boston, MA. Leerink Partners Global Healthcare Conference : Fireside chat at 4:20 p.m. ET on Tuesday, March 10, 2026 , in Miami, FL. A live webcast of the presentations will be available on the Investors page of Century’s website at www.centurytx.com . Archived replays will be available for at least 30 days. About Century Therapeutics Century Therapeutics (NASDAQ: IPSC) is a biotechnology company advancing a pipeline of induced pluripotent stem cell (iPSC)-derived cell therapies with the potential to meaningfully address autoimmune diseases, including type 1 diabetes, and cancer. The company’s therapies are derived from its iPSC cell foundry and leverage its novel immune evasion engineering technology, Allo-Evasion™. Century believes its approach to developing off-the-shelf cell therapies will expand patient access and provide advantages over existing cell therapies which will ultimately advance the course of care. For more information on Century Therapeutics , please visit www.centurytx.com and connect with us on LinkedIn. For More Information: Century Therapeutics Douglas Carr Senior Vice President, Finance [email protected] JPA Health Sarah McCabe [email protected] Source: Century Therapeutics, Inc.

View stock analysis, news, and events for Century Therapeutics, Inc.